Cleared Traditional

K053640 - INTEGRA

K053640 is an FDA 510(k) clearance for INTEGRA, manufactured by Direx Systems Corp.. The device is a Class 2 Gastroenterology & Urology device with product code LNS cleared through the Traditional 510(k) pathway after a 61-day FDA review.

K053640 · Direx Systems Corp. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
61d
Days
Class 2
Risk

K053640 is an FDA 510(k) clearance for the INTEGRA. Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Direx Systems Corp. (Canton, US). The FDA issued a Cleared decision on March 1, 2006 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Direx Systems Corp. devices

FDA 510(k) Submission Details - K053640

510(k) Number K053640 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 2005
Decision Date March 01, 2006
Days to Decision 61 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 131d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNS Device Classification - Class 2, Special Controls

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 41
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K053640.
LITHODIAMOND ULTRA
K061350 · Pck Electronic Industry & Trade Co., Ltd. · Dec 2006
LITHOGOLD
K062081 · Tissue Regeneration Technologies, Inc. · Nov 2006
INTEGRA SL
K062147 · Direx Systems Corp. · Oct 2006
TRIPTER-X1 COMPACT DUET SP (SEPARATED PULSE)
K050091 · Direx Systems Corp. · Mar 2005
GENESTONE EXEL (XL) EXTRACORPOREAL SHOCK WAVE LITHOTRIPTER
K042427 · Genemed, Inc. · Dec 2004
TWINHEADS TH-103 EXTRACORPOREAL SHOCK WAVE LITHOTRIPTER
K042561 · Fmd, LLC · Oct 2004